 The optimal treatment for patients with cervical cancer on FIGO stage IB2 and IIB is controversial. There is no randomized comparison of a dose-dense NACT TP or TIP-schedule followed by hysterectomy and LNE investigational Arm A versus primary chemo-radiation standard arm B. Primary endpoint is the DFS at 5 years, secondary endpoints local control at 5 years, OS at 5 years, QOL, questionnaires on sexual activityQOL. 